Certified by Founder Lodge
Neurophth Therapeutics / 纽福斯生物科技有限公司
China - Wuhan / 武汉
START UP
1 Disclosed Funding Rounds $95,000,000
0 Participating Investments
-
Founded date
2016
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
At Neurophth, we walk from obstacle to obstacle without loss of enthusiasm.
在纽福斯公司，我们是从一个障碍走向另一个障碍而不丧失热情。
We are China’s first gene therapy company for ophthalmic
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| August, 14 ,2023 | Series C | $95,000,000 |
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Helex | $3,500,000 | (Nov 4, 2025)
xMEMS | $21,000,000 | (Nov 4, 2025)
catalyx space | $5,400,000 | (Nov 4, 2025)
Cephia AI | $4,000,000 | (Nov 4, 2025)
Ornn | $5,700,000 | (Nov 4, 2025)
